Evidence map›Paper›PMID 33002337›Full record

Observational studyArthritis care & research2021

Data-Driven Patient Clustering and Differential Clinical Outcomes in the Brigham and Women's Rheumatoid Arthritis Sequential Study Registry.

Jeffrey R Curtis, Michael Weinblatt, Kenneth Saag, Vivian P Bykerk, Daniel E Furst, Stefano Fiore, Gregory St John, Toshio Kimura, Shen Zheng, Clifton O Bingham and 5 more

Open access · hybridAbstract readObservational Study
In one paragraph

Observational study in Arthritis care & research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Observational
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. [A cross-sectional study on the clinical phenotypes of rheumatoid arthritis].Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences · 2022
    Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 10 institutions in 3 countries.

Jeffrey R CurtisUniversity of Alabama at Birmingham.ORCID 0000-0002-8907-8976
Michael WeinblattBrigham and Women's Hospital, Boston, Massachusetts.
Kenneth SaagUniversity of Alabama at Birmingham.ORCID 0000-0001-6189-8078
Vivian P BykerkHospital for Special Surgery, New York, New York.
Daniel E FurstUniversity of California, Los Angeles, University of Washington, Seattle, and University of Florence, Florence, Italy.
Stefano FioreSanofi, Bridgewater, New Jersey.
Gregory St JohnRegeneron Pharmaceuticals, Tarrytown, New York.
Toshio KimuraRegeneron Pharmaceuticals, Tarrytown, New York.
Shen ZhengSanofi, Bridgewater, New Jersey.
Clifton O BinghamJohns Hopkins University, Baltimore, Maryland.ORCID 0000-0002-4752-5029
Grace WrightPrivate Practice, New York, New York.
Martin BergmanDrexel University College of Medicine, Philadelphia, Pennsylvania.ORCID 0000-0002-8948-5264
Kamala NolaLipscomb University College of Pharmacy and Health Sciences, Nashville, Tennessee.
Christina Charles-SchoemanUniversity of California, Los Angeles.
Nancy ShadickBrigham and Women's Hospital, Boston, Massachusetts.ORCID 0000-0003-3953-845X
Brigham and Women's Hospital · USRegeneron (United States) · USSanofi (United States) · USUniversity of Alabama at Birmingham · USUniversity of California, Los Angeles · USDrexel University · USHospital for Special Surgery · USIS practice · BEJohns Hopkins University · USLipscomb University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo use unbiased, data-driven, principal component (PC) and cluster analysis to identify patient phenotypes of rheumatoid arthritis (RA) that might exhibit distinct trajectories of disease progression, response to treatment, and risk for adverse events.

methodsPatient demographic, socioeconomic, health, and disease characteristics recorded at entry into a large, single-center, prospective observational registry cohort, the Brigham and Women's Rheumatoid Arthritis Sequential Study (BRASS), were harmonized using PC analysis to reduce dimensionality and collinearity. The number of PCs was established by eigenvalue >1, cumulative variance, and interpretability. The resulting PCs were used to cluster patients using a K-means approach. Longitudinal clinical outcomes were compared between the clusters over 2 years.

resultsAnalysis of 142 variables from 1,443 patients identified 41 PCs that accounted for 77% of the cumulative variance in the data set. Cluster analysis distinguished 5 patient clusters: 1) less RA disease activity/multimorbidity, shorter RA duration, lower incidence of comorbidities; 2) less RA disease activity/multimorbidity, longer RA duration, more infections, psychiatric comorbidities, health care utilization; 3) moderate RA disease activity/multimorbidity, more neurologic comorbidity; 4) more RA disease activity/multimorbidity, shorter RA duration, more metabolic comorbidity, higher body mass index; 5) more RA disease activity/multimorbidity, longer RA duration, more hepatic, orthopedic comorbidity and RA-related surgeries. The clusters exhibited differences in clinical outcomes over 2 years of follow-up.

conclusionData-driven analysis of the BRASS registry identified 5 distinct phenotypes of RA. These results illustrate the potential of data-driven patient profiling as a tool to support personalized medicine in RA. Validation in an independent data set is ongoing.

Indexed as

Arthritis, RheumatoidAdolescentAdultAgedAged, 80 and overBostonCluster AnalysisCross-Sectional StudiesData MiningDisease ProgressionFemaleHealth StatusHumansIncidenceMaleMiddle Aged

Identifiers

PMID33002337
PMCPMC8048846
OpenAlexW3090177930

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.